BioNTech SE (BNTX)

BioNTech SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,093	9,762	11,664	13,875	1,693	1,210
Short-Term Investments	4,435	7,022	4,885	189.4	381.6	137.2
Cash & Short-Term Investments	14,528	16,784	16,549	14,065	2,074	1,347
Cash Growth	-13.06%	1.42%	17.66%	578.04%	53.95%	158.70%
Accounts Receivable	699.7	1,474	2,161	7,146	12,382	165.5
Other Receivables	84.8	50	179.1	0.4	0.4	0.9
Receivables	784.5	1,524	2,340	7,146	12,382	166.4
Inventory	225.7	283.3	357.7	439.6	502.5	64.1
Other Current Assets	292.9	212.7	280.9	271.9	113.4	89
Total Current Assets	15,831	18,804	19,527	21,922	15,072	1,667
Property, Plant & Equipment	1,241	1,183	971.6	821.1	520.4	326
Long-Term Investments	2,476	1,254	1,176	80.2	21.3	-
Goodwill	357.7	380.6	362.5	61.2	57.8	53.7
Other Intangible Assets	1,390	767.7	781.7	145.4	136.8	103.8
Long-Term Accounts Receivable	3.9	9.8	-	-	-	-
Long-Term Deferred Tax Assets	17.7	81.7	81.3	229.6	-	161.2
Other Long-Term Assets	24.6	49	105.8	19.6	22.2	7
Total Assets	21,341	22,530	23,006	23,279	15,831	2,319
Accounts Payable	399.8	426.7	354	204.1	160	102.3
Current Portion of Long-Term Debt	-	-	-	-	102	3
Current Portion of Leases	53.4	39.5	28.1	36	27.9	6.1
Current Income Taxes Payable	6.3	4.5	525.5	595.9	1,569	-
Current Unearned Revenue	796.1	294.9	353.3	77.1	186.1	391.6
Other Current Liabilities	966.9	1,758	809.6	2,038	1,437	103
Total Current Liabilities	2,223	2,523	2,071	2,951	3,482	606
Long-Term Debt	-	-	2.4	2.1	17.9	152.9
Long-Term Leases	192	214.7	188.6	174.1	153.7	78.1
Long-Term Unearned Revenue	219	183	398.5	48.4	9	71.9
Long-Term Deferred Tax Liabilities	24.2	42.4	39.7	6.2	66.7	0.2
Other Long-Term Liabilities	206.1	155.3	60.7	42.1	208.2	37.7
Total Liabilities	2,864	3,119	2,760	3,224	3,937	946.8
Common Stock	248.6	248.6	248.6	248.6	246.3	246.3
Retained Earnings	18,267	19,098	19,763	18,833	9,883	-409.6
Treasury Stock	-8.1	-8.6	-10.8	-5.3	-3.8	-4.8
Comprehensive Income & Other	-30.1	73.1	244.8	979.3	1,768	1,540
Total Common Equity	18,477	19,411	20,246	20,056	11,894	1,372
Shareholders' Equity	18,477	19,411	20,246	20,056	11,894	1,372
Total Liabilities & Equity	21,341	22,530	23,006	23,279	15,831	2,319
Total Debt	245.4	254.2	219.1	212.2	301.5	240.1
Net Cash (Debt)	14,282	16,529	16,330	13,852	1,773	1,107
Net Cash Growth	-13.26%	1.22%	17.89%	681.38%	60.10%	147.93%
Net Cash Per Share	59.51	68.76	67.28	55.45	6.83	4.46
Filing Date Shares Outstanding	240.46	239.97	237.73	240.99	242.52	241.52
Total Common Shares Outstanding	240.46	239.97	237.73	243.22	242.52	241.52
Working Capital	13,608	16,280	17,457	18,971	11,591	1,061
Book Value Per Share	76.84	80.89	85.16	82.46	49.04	5.68
Tangible Book Value	16,730	18,263	19,102	19,849	11,699	1,214
Tangible Book Value Per Share	69.58	76.10	80.35	81.61	48.24	5.03
Land	-	369.4	235.4	217	104.1	61.3
Machinery	-	427.7	344.1	273	198.3	142.4
Construction In Progress	-	460.6	389.5	235.5	94.3	81.6

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q